Objective: Early diagnosis and treatment of children with congenital hypothyroidism (CH) through newborn screening can effectively prevent delayed development in children. This study was designed to investigate the pathogenesis and influencing factors of CH in urban areas of China between 2009 and 2018. Methods: A retrospective analysis of newborn screening data and diagnosis and treatment information for CH diagnosed in the information database of the neonatal disease screening center in one of China's five special economic zones from 2009 to 2018. Results: Of the 947,258 newborns screened between 2009 and 2018, 829 (406 girls)
Introduction
Congenital hypothyroidism (CH) is a common congenital endocrine disease and includes congenital development and ectopy or functional defects of thyroid tissue. If not treated in a timely fashion, it can lead to delayed growth and intellectual disability.
Clinically, CH is divided into two types, according to the duration of hypothyroidism: permanent CH (permanent congenital hypothyroidism, PCH) and transient CH (transient congenital hypothyroidism, TCH). The etiology of CH includes genetic and various environmental factors, and the incidence is geographically and ethnically varied. The traditional incidence is 1/3000-1/4000 (1) .
In recent years, the incidence of CH has shown a global upward trend. In New York, the incidence of CH increased by 138% over 27 years (from 1/3448 in 1978 to 1/1429 in 2005) (2) . In Western Australia, the incidence of CH increased from 1/5882 between 1981 and 1987, to 1/2857 between 1988 and 1998 (3) . In China, from 1985 to 2006, the total incidence of CH was 1/2041, and the incidence showed an increasing trend year on year. The prevalence rate before 1991 was 1/4000, reaching a peak of 1/1613 in 2003 and decreased to 1/1724 in 2006. It is worth noting that the incidence of CH has been stable at a low level before 1998, with an average of 1/5000. From 1998 to 2006, the incidence of CH increased significantly, with an average of 1/1923. This is primarily attributable to improvement of the testing methods and increase in the recall rate of children suspected of having CH (4) . However, the conclusions on the incidence of PCH and TCH and their influencing factors are not consistent (5) (6) .
In the 1980s, China began to promote screening for neonatal diseases. In October 1994, the Law of the People's Republic of China on Maternal and Infant Health was promulgated, which provided effective policy support for screening newborns.
Newborn screening entered a period of rapid development (7) . Xiamen is located on the southeast coast of China and is more economically developed than most other regions of China, designated as one of the five special economic zones in China. In January 2002, the municipal government of Xiamen established a neonatal disease screening center. This, along with the implementation of the "Newborn Disease Screening Management Network System" in 2009, has resulted in formation of a relatively complete screening and management network.
Despite the aforementioned policies, no studies on CH have been conducted in
Xiamen in recent years. The purpose of this study is to analyze the characteristics of the pathogenesis and influencing factors of CH in the past 10 years by analyzing the screening and diagnosis information of CH in Xiamen City from 2009 to 2018 and to explore the causes of CH, provide direction for further research, and to provide evidence for corresponding intervention measures.
Materials and Methods

Source of data
This article reviews the information on newborn screening (screening number and 
Patient Population
From January 2009 to December 2018, the total number of live births in Xiamen totaled 998,198, and the number of newborns screened reached 947,258 (47.3% girls), of which 829 (49.0% girls) were diagnosed with CH and received levothyroxine treatment. We detailed the age at screening for all children, the TSH concentration of newborn screening results, the thyroid function test results at diagnosis (TT4, FT4, TSH), gender, gestational age, and thyroid imaging results (if performed).
Screening Method
Heel prick blood was obtained from newborns 72 hours after establishing breastfeeding. The blood sample was dropped on S&S Grade 903 filter paper, 3 blood spots each ≥ 8mm, and sent to the laboratory for inspection within 5 working days after drying. Thyroid stimulating hormone (TSH) was selected as the screening parameter, and time-resolved fluorescence immunoassay (DELFIA) was used for the screening test. The instrument used was a DELFIA-1420 analyzer (Wallac, Finland).
The company's matching newborn screening TSH test kit was also used. Basis of judgment was as follows: The TSH concentration was used as the initial screening index with a cut-off value of 9mIU/L. If the value was higher than the cut-off, the original specimen was reviewed. If TSH ≥20mIU/L, patients were recalled to undergo venous sampling for serum TT4, FT4, and TSH evaluation. If the TSH concentration was ≥9mIU/L and <20mIU/L, infants were recalled for a second heel-prick sample at 7-14 days of life. If the second sample yielded TSH＜9mIU/L, the infant was considered to have transient TSH elevation, and were excluded from the study. If the second sample yielded TSH ≥9mIU/L, infants were recalled again to undergo venous sampling to test for serum TT4, FT4, and TSH for confirmation of diagnosis ( Figure   1A ). Based on venous results, neonates were considered to have CH if their TSH was >10 mIU/L and/or TT4 (total thyroxin) <6.5μg/dl (8) . Physical examination was carried out and those with a confirmed diagnosis were treated with levothyroxine sodium (L-T4). Before treatment, infants with CH underwent thyroid scintigraphy with technetium pertechnetate (whenever feasible) to determine the etiology of CH.
Thyroid ultrasonography was performed when scintigraphy showed no uptake in the thyroid gland area to confirm thyroid agenesis. When the thyroid scintigraphy was normal or indicative of a goiter, ultrasonography was performed to confirm whether a goiter was present.
Grouping Criteria
Grouping criteria for neonatal births: (1) gestational age and birth weight: preterm birth: <37 weeks, full-term birth: 37 to <42 weeks: post-term birth ≥42 weeks; low birth weight: <2,500 g, normal birth weight: 2,500~< 4,000 g, macrosomia ≥4,000 g; (2) birth season (divided by seasonal temperature characteristics): April to September were designated as warm months, October to March of the next year were designated as cool months. (3) Serum FT4 levels: mild (10-15 pmol/L), moderate (5-9.9 pmol/L), and severe (<5 pmol/L) (9) . (4) Initial serum TSH concentration: (i) 10-20 mIU/L, (ii) 21-40 mIU/L, (iii) 41-100 mIU/L, (iv) ≥100 mIU/L.
Detailed Follow-up
All patients diagnosed with CH from 2009 to 2015 were reassessed at ≥3 years old, and in order to distinguish between permanent and transient cases of CH, levothyroxine therapy was discontinued for 5 weeks in children who were 3 years old (5) . However, in patients with a known permanent form of CH (ectopy or agenesis) confirmed by scintigraphy and ultrasonography, therapy was not discontinued.
Thyroid function tests (FT4 and TSH) were evaluated after discontinuing treatment for 5 weeks. If the thyroid function tests showed TSH >10 mIU/L, PCH was diagnosed and L-T4 was restarted. Patients with TSH <5.5mIU/L were considered to have had TCH. If the patient's serum TSH concentration was slightly elevated (5.5-10mIU/L), the patients were managed, and if the mild hyperthyroptropinaemia persisted, they were evaluated with a thyrotropin-releasing hormone (TRH) test to confirm primary hypothyroidism (10) . If primary hypothyroidism was confirmed, L-T4 was restarted, and PCH diagnosis was confirmed ( Figure 1B ).
Statistical Analysis
All statistical analyses were performed by using SPSS 22.0 (IBM SPSS Statistics, IBM Corporation, Armonk, NY). Because of the non-normal distribution of data, statistical analyses are presented as medians and interquartile ranges (25th and 75th percentile). The Mann-Whitney U test was used to compare groups of non-normally distributed data, and Chi-square test was used for normally distributed data.
One-way ANOVA was used for group comparisons. A P-value of <0.05 was considered statistically significant.
Results
CH screening and overall incidence
From January 2009 to December 2018, the total number of live births in Xiamen totaled 998,198, and the number of newborns screened was 947,258 (94.90%). The screening rate of newborns increased year on year, from 90.64% in 2009 to 99.10% in 2018 ( Figure 2A ). Of these, 829 (406 girls) were diagnosed with CH at birth (incidence: 1/1136) and 48 infants (5.79%) were preterm. The number of confirmed cases of CH at birth increased from 66 in 2009 (1/1176) to 101 in 2011 (1/909), and then gradually decreased to 81 (1/1020) in 2015, and then fell to 62 in 2018 (1/1176) (χ2=15.49, P>0.05) ( Figure 2B ). 
Features
Incidence of CH According to Severity
Between 2009 and 2018, the change in incidence of CH diagnosed at birth was significantly higher in infants with initial serum TSH concentrations of 41-100 mIU/L and ≥100 mIU/L. The incidence of the former showed a slight increase, and the incidence of the latter decreased. However, in infants with initial serum TSH concentrations of 8-20 mIU/L and 21-40 mIU/L, the CH incidence was relatively stable (Figure 3) . By comparing the incidence of CH diagnosed at birth with different severities, the results showed that the incidence of mild CH varied greatly, showing a trend of slight increase; the incidence of severe CH decreased, while the incidence of moderate CH remained relatively stable (Figure 4 ).
Risk factors affecting the incidence of CH
Univariate analysis of gender, gestational age, birth weight, and birth season variables for the incidence of CH diagnosed at birth between 2009 and 2018 showed that the incidence of CH was significantly higher in post-term infants (1/63) than in term infants (1/1191) with the difference statistically significant (χ2 = 487.98, P<0.001). The incidence of CH in low birth weight patients (1/370) was significantly higher than normal birth weight (1/1227), the difference was statistically significant (χ2=141.71, P<0.001). There was no significant difference in the incidence of CH between different seasons ( Table 2) .
TCH versus PCH in patients diagnosed with CH between 2009 and 2015 and reevaluated at the age of 3 years
The incidence of transient and permanent CH in children >3 years of age is presented in Figure 5 . Among the 608 cases of CH diagnosed during the neonatal period and reevaluated at the age of 3 years, 487 cases were confirmed to be permanent (PCH, 1/1429) and 121 cases were considered as being transient (TCH, 1/5882). The ratio of PCH to TCH was 1:0.25. The incidence of PCH rose from 1/1333 in 2009 to 1/1136 in 2011, and then gradually decreased to 2015, which increased to 1/1190 (χ2=13.74, P<0.05). The incidence of TCH increased from 1/10,000 in 2009 to 1/3846 in 2012 and then gradually declined to 2015 again rising to 1/7692 (χ2=15.30, P<0.05) ( Figure 5 ).
Further comparison of the imaging characteristics in the neonatal period of those confirmed to have PCH and TCH found that a total of 466 infants (405 cases of PCH, 61 cases of TCH) underwent thyroid imaging. There were 116 cases of thyroid dysgenesis in 405 cases of PCH (67 agenesis, 11 ectopy, 38 hypoplasia), accounting for 28.64%. The thyroid imaging showed orthotopic glands were in 289 cases (100 of normal size, 189 goiters), accounting for 71.36%. In 61 cases of TCH, thyroid imaging was of normal size in 22 cases and goiters in 39 cases. A comparison of these children with PCH or TCH who had orthotopic glands (normal size or goiter) on neonatal thyroid imaging is presented in Table 3 . Higher male-to-female sex ratio was associated with an increased likelihood of PCH.
With regards to PCH incidence, males were significantly overrepresented as compared to females (χ2=12.15, P<0.01), and post-term infants had a significantly higher incidence than term (χ2=6.51, P<0.05); low birth weight (χ2=12.57, P<0.001) and macrosomic infants (χ2=7.66, P<0.01) had a significantly higher incidence than those with normal birth weight. The incidence of TCH in post-term infants was significantly higher than the term (χ2=13.30, P<0.001), and those with low birth weight had a significantly higher incidence than those with normal birth weight (χ2=20.88, P<0.001) ( Table 4 ).
Discussion
Studies have shown that the incidence of CH diagnosed at birth in Xiamen between 2009 and 2018 fluctuated with time and the average incidence rate was 1/1136. Re-evaluation at 3 years of age, PCH incidence was 1/1429, significantly higher than worldwide incidence of CH (1/3000-1/4000) (11) . In the past two decades, Western countries have conducted extensive research on CH but there few studies have focused on the incidence of CH in China. Data collected from the National Newborn Screening Database show that the incidence of CH from 1985 to 2007 was 1/2041 (12) , while the incidence of CH from 2013 to 2015 was 1/2439 (13) . In addition, changes related to geography in CH incidence were observed. Previous studies have shown that the incidence of CH is higher in coastal and inland areas, while the incidence in remote areas is lower (13) . This study shows that the incidence of CH in the Xiamen area has been significantly higher than the national incidence in Western countries have shown that with the increase in the survival rate of premature infants, the incidence of neonatal CH increases year on year (14) (15) . Therefore, we speculate that with the improvement of the level of neonatal care in Xiamen, the survival rate of preterm infants increased, thus the higher incidence of CH. However, only 5.79% of those diagnosed with CH in this study were preterm, so the increase in the survival rate of preterm infants does not fully explain the increase in CH incidence in Xiamen. Third, this rise may be attributable to environmental risk factors related to the onset of CH, such as deficiency or excess of iodine (11, 16) . Iodination of salt has been shown to be the ideal way of supplementing iodine in the diet and has been recognized by public health agencies in different countries as safe, effective, and economical. With iodine deficiency being all but eliminated, CH due to excessive iodine intake has not yet become emphasized by clinicians. Xiamen is located on the southeast coast of China, where salt is iodized, seafood is plentiful and a staple in the local cuisine, therefore leading to the possibility of excessive iodine intake, so the increase in the incidence of CH may also be related to excessive iodine intake. In addition, it may also be related to the distribution of the population carrying a gene susceptible to CH.
The findings from this study show that the incidence of CH in Xiamen increased in the past decade, mainly due to the increase in the incidence of PCH and TCH. The incidence rates of PCH and TCH were 1/1429 and 1/5882, respectively. In the pretext of consistent screening methods, the incidence of PCH and TCH still increased significantly, suggesting that methodological factors are not the cause of the increase in the incidence of CH in Xiamen. Approximately 10 to 15% of CH patients are diagnosed as having TCH (17) . In this study, just under 20% of the neonates diagnosed with CH at birth are deemed having TCH by the age of 3. The high incidence of TCH may be attributable a number of factors, including iodine excess, TSH receptor inhibition due to transplancentally transmitted autoantibodies, elevated thyroid autoantibodies, intake of antithyroid agents or use of disinfectants containing iodine, and maternal use of TSH and/or drugs affecting the thyroid. Low birth weight (<1500g) and preterm birth (<37 weeks GA) may cause immature thyroid organogenesis, as can genetic mutations (18) (19) (20) (21) . Ordookhani et al identified elevated urine iodine concentration as the most common cause of neonatal TCH (22) . A limitation of our study is that we did not measure urine iodine concentration of infants in the study. There is a need to further investigate the reasons behind increased incidence of TCH with particular emphasis on the effect of excessive iodine.
According to the imaging results in this study, we found that 70.8% of CH had normal-sized orthotopic glands or a goiter, while the proportion of permanent CH in this group was 82.6%, which was significantly higher figure of 35% observed in a recent Korean study (23) . This study found that 80.1% of children with CH developed permanent CH after 3 years, which is significantly higher than the 60% to 64% reported in previous studies (24) (25) (26) .
The causes of CH include genetic and environmental factors. Functional defects are mainly caused by genetic abnormalities, while developmental and ectopy are more related to environmental factors (27) . Among factors at birth, female sex, preterm birth, post-term birth, low birth weight, macrosomia, low temperature, and use of iodine disinfectants are risk factors for CH (28) (29) . There is increasing evidence of the role of sex dimorphism in CH. Studies have shown that there is female preponderance in thyroid agenesis and ectopy (30) . However, the results of our study on the sex ratio of CH show that there is female preponderance in ectopy but not in agenesis. Sex dimorphism is only present in ectopia, which is consistent with the results of Eugene et al (31) (32) . Unfortunately, in this study, the sample size of ectopy was small, and larger studies are needed in the future to assess the impact of sex dimorphism in thyroid dysplasia. Previous research suggests that sex differences in the fetal period can regulate the development of the thyroid gland, and sex dimorphism as a regulatory factor may regulate the genetic and molecular mechanisms of early development, differentiation and migration of the thyroid gland (30) . Future work on CH etiology and molecular genetics research need to further consider the impact of sex dimorphism. This study shows that post-term births and low birth weight are important factors influencing the changes in the incidence of CH in newborns. PCH is associated with post-term birth, low birth weight, and macrosomia, while TCH is associated with post-term birth and low birth weight. The pathogenic mechanism of the above factors is not completely clear. Low birth weight may be caused by immature thyroid function, insufficient iodine reserves, or deficits in thyroid development. The mechanism of post-term birth and macrosomia is unknown, and further research is needed. This study did not find a relationship between birth season and the incidence of CH, but this may be related to the region's subtropical climate or seasonal grouping.
Conclusions
Our study demonstrates that in the past decade, the incidence of CH in Xiamen has increased, mainly due to an increase in the incidence of PCH and TCH, and the incidence of mild CH has risen slightly, mainly in those with a normal thyroid or goiter. Post-term birth and low birth weight are important factors influencing the change of CH incidence in neonates. In future epidemiological investigations, we will continue to study other potential causes of CH, such as iodine deficiency or excess and environmental factors, and genes susceptible to CH. 
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